KTOV vs. OBSV, CYCN, GRAY, TRVN, VAXX, BNOX, CANF, EFTR, OGEN, and VIRI
Should you be buying Purple Biotech stock or one of its competitors? The main competitors of Purple Biotech include ObsEva (OBSV), Cyclerion Therapeutics (CYCN), Graybug Vision (GRAY), Trevena (TRVN), Vaxxinity (VAXX), Bionomics (BNOX), Can-Fite BioPharma (CANF), eFFECTOR Therapeutics (EFTR), Oragenics (OGEN), and Virios Therapeutics (VIRI). These companies are all part of the "medical" sector.
Purple Biotech (NASDAQ:KTOV) and ObsEva (NASDAQ:OBSV) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation.
In the previous week, ObsEva had 1 more articles in the media than Purple Biotech. MarketBeat recorded 1 mentions for ObsEva and 0 mentions for Purple Biotech. Purple Biotech's average media sentiment score of 0.00 equaled ObsEva'saverage media sentiment score.
Purple Biotech has a beta of 2.37, suggesting that its stock price is 137% more volatile than the S&P 500. Comparatively, ObsEva has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500.
Purple Biotech's return on equity of 0.00% beat ObsEva's return on equity.
30.7% of Purple Biotech shares are owned by institutional investors. Comparatively, 17.5% of ObsEva shares are owned by institutional investors. 3.0% of Purple Biotech shares are owned by company insiders. Comparatively, 14.4% of ObsEva shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Purple Biotech has higher earnings, but lower revenue than ObsEva. Purple Biotech is trading at a lower price-to-earnings ratio than ObsEva, indicating that it is currently the more affordable of the two stocks.
ObsEva received 108 more outperform votes than Purple Biotech when rated by MarketBeat users. However, 72.76% of users gave Purple Biotech an outperform vote while only 53.52% of users gave ObsEva an outperform vote.
Summary
Purple Biotech and ObsEva tied by winning 6 of the 12 factors compared between the two stocks.
Get Purple Biotech News Delivered to You Automatically
Sign up to receive the latest news and ratings for KTOV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KTOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Purple Biotech Competitors List
Related Companies and Tools
